Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Carpe Diem launches a New Pension Model on the Blockchain
-
Casella Waste Systems, Inc. to Present at Upcoming Investor Conferences
-
FRTIB Awards $50.8M Cybersecurity Contract to ShorePoint
-
Investeringsforeningen Multi Manager Invest - ophævelse af suspension
-
Arcadia Launches Data Platform to Unlock Speed, Reliability, and Scale for Healthcare Enterprises
-
No. 4/2024 - Notice to convene annual general meeting
-
Alliance Trust PLC - Net Asset Value
-
Investeringsforeningen Nykredit Invest Balance - ophævelse af suspension
-
Investeringsforeningen Investin - ophævelse af suspension
-
Equifax Canada: Economic Pressures has Fraud and Auto Theft on the Minds of Canadians
-
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
-
Cumulus Media Announces Exchange Offer and Consent Solicitation Relating to 6.750% Senior Secured First-Lien Notes due 2026
-
Brera Holdings Signs All-Star Advisory Board to Lead Soccer World’s First Nasdaq-Listed Multi-Club Ownership Model
-
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
-
ArtsKC Launches The Drop, Regional Arts & Culture Access Program
-
ArtsKC Launches The Drop, Regional Arts & Culture Access Program
-
Red8 Recognized on CRN’s 2024 MSP 500 List in the Elite 150 Category
-
Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated wi
-
Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with A
-
Osisko Metals Establishes a Technical Consultation Committee to Develop the Pit Dewatering Plan for Gaspé Copper
-
Land and Economic Reconciliation: Cambium Inc. and Cambium Indigenous Professional Services Forge Groundbreaking Agreement
-
Canadian Consumer Credit Market Reaches a New High, Driven by Credit Demand from New-to-Credit Canada Consumers
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
-
Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference
-
English language groups host discussion on the future vitality of Quebec’s English-speaking community
-
Jnana Therapeutics to Participate in Upcoming Investor Conferences
-
Volaris Acquires Zeit AG
-
Earlyworks selected as a co-creation partner for MetaMe® a meta-communication service utilizing cutting-edge technology from NTT DOCOMO, one of Japan's largest cell phone operators!
-
Plus Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on March 5, 2024
-
Recce Pharmaceuticals Announces Expansion of Phase I/II Trial of RECCE® 327 for the Treatment of Diabetic Foot Infections
-
Pramana Joins Proscia Ready To Help Laboratories Realize More Value From Their Pathology Data
-
Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and China
-
Portillo’s Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
-
Lightbridge CEO Seth Grae Issues Update Letter to Shareholders
-
Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results
-
Cumulus Media Reports Operating Results for 2023
-
VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium
-
Denali Therapeutics Announces $500 million Private Placement Equity Financing
-
Madison Realty Capital Completes More Than $3 Billion in Transactions in 2023
-
Ardelyx to Participate at the Cowen 44th Annual Health Care Conference
-
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
-
Vittoria Therapeutics Announces Appointment of Life Sciences Veteran Rosemary Mazanet, M.D., Ph.D. as Chief Medical Officer
-
CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder Cancer
-
Blade Air Mobility Announces Opening of Investor Q&A Platform Ahead of its Release of Fiscal Fourth Quarter 2023 Financial Results
-
CytomX Therapeutics to Present at Upcoming March Investor Conferences
-
Cerence Announces Its Participation at Two Upcoming Investor Conferences
-
MedMatrix Product Moves from Beta to Full Commercialization, Announces AI Product Suite
-
Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea
-
NEC X Invests in Technology Startup, WeWALK, to Advance Mobility Solutions for Visually Impaired People
-
Puma Exploration Launches its 2024 Drilling Program at Williams Brook
